PharmaSGP Holding SE
PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil … Read more
Market Cap & Net Worth: PharmaSGP Holding SE (PSG)
PharmaSGP Holding SE (F:PSG) has a market capitalization of $340.34 Million (€331.56 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #26190 globally and #2865 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PharmaSGP Holding SE's stock price €28.80 by its total outstanding shares 11512500 (11.51 Million).
PharmaSGP Holding SE Market Cap History: 2020 to 2025
PharmaSGP Holding SE's market capitalization history from 2020 to 2025. Data shows change from $269.28 Million to $340.34 Million (-2.21% CAGR).
PharmaSGP Holding SE Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PharmaSGP Holding SE's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.41x
PharmaSGP Holding SE's market cap is 2.41 times its annual revenue
Latest Price to Earnings (P/E) Ratio
14.64x
PharmaSGP Holding SE's market cap is 14.64 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $269.28 Million | $63.25 Million | $10.64 Million | 4.26x | 25.31x |
| 2021 | $266.06 Million | $65.34 Million | $10.69 Million | 4.07x | 24.89x |
| 2022 | $274.36 Million | $85.82 Million | $11.95 Million | 3.20x | 22.95x |
| 2023 | $240.42 Million | $101.10 Million | $16.40 Million | 2.38x | 14.66x |
| 2024 | $285.98 Million | $118.84 Million | $19.54 Million | 2.41x | 14.64x |
Competitor Companies of PSG by Market Capitalization
Companies near PharmaSGP Holding SE in the global market cap rankings as of March 19, 2026.
Key companies related to PharmaSGP Holding SE by market ranking:
- Sejal Glass Limited (NSE:SEJALLTD): Ranked #26181 globally with a market cap of $17.13 Million USD ( ₹1.48 Billion INR).
- authID Inc. (NASDAQ:AUID): Ranked #26182 globally with a market cap of $17.13 Million USD.
- HeraMED Limited (F:1I4): Ranked #26191 globally with a market cap of $17.10 Million USD ( €16.66 Million EUR).
- Prestige Wealth Inc. (NASDAQ:AURE): Ranked #26192 globally with a market cap of $17.10 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #26181 | Sejal Glass Limited | NSE:SEJALLTD | $17.13 Million | ₹495.00 |
| #26182 | authID Inc. | NASDAQ:AUID | $17.13 Million | $1.45 |
| #26191 | HeraMED Limited | F:1I4 | $17.10 Million | €0.02 |
| #26192 | Prestige Wealth Inc. | NASDAQ:AURE | $17.10 Million | $1.78 |
PharmaSGP Holding SE Historical Marketcap From 2020 to 2025
Between 2020 and today, PharmaSGP Holding SE's market cap moved from $269.28 Million to $ 340.34 Million, with a yearly change of -2.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €340.34 Million | +19.01% |
| 2024 | €285.98 Million | +18.95% |
| 2023 | €240.42 Million | -12.37% |
| 2022 | €274.36 Million | +3.12% |
| 2021 | €266.06 Million | -1.19% |
| 2020 | €269.28 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of PharmaSGP Holding SE was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $340.34 Million USD |
| MoneyControl | $340.34 Million USD |
| MarketWatch | $340.34 Million USD |
| marketcap.company | $340.34 Million USD |
| Reuters | $340.34 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.